Welcome to Scholar Publishing Group

International Journal of World Medicine, 2022, 3(2); doi: 10.38007/IJWM.2022.030205.

Professor Li Yi's Experience in Treating Ulcerative Colitis with the Method of Warming Yang and Activating Blood Circulation

Author(s)

Yujiao Xue, Yi Li, Hui Zhang and Changan Zhou

Corresponding Author:
Yi Li
Affiliation(s)

Department of Digestion, Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Xianyang 712000, Shaanxi, China

Abstract

Professor Li Yi believes that the pathogenesis of ulcerative colitis is based on yang deficiency and blood stasis as the standard, and the methods of warming the spleen and kidney, activating blood circulation and removing blood stasis should be used in clinical prescriptions, supplemented with products of clearing heat, dampness and detoxification, and treated based on syndrome differentiation, in order to achieve the purpose of invigorating yang and dispelling evil, evil removing Zhengan, evil removing Yang recovery, clinical symptoms are often treated with self-made Fuyang jiedu Huoxue decoction, special prescriptions for special diseases, and flexible changes. The curative effect is quite good in improving patients' clinical symptoms and shortening the course of disease, in order to provide reference and new ideas for the clinical treatment of this disease. 

Keywords

Ulcerative Colitis, Spleen and Kidney Yang Deficiency, Warming Yang, Activating Blood, Syndrome Differentiation And Treatment Of Supporting Upright and Dispelling Pathogen

Cite This Paper

Yujiao Xue, Yi Li, Hui Zhang and Changan Zhou. Professor Li Yi's Experience in Treating Ulcerative Colitis with the Method of Warming Yang and Activating Blood Circulation. International Journal of World Medicine (2022), Vol. 3, Issue 2: 36-41. https://doi.org/10.38007/IJWM.2022.030205.

References

[1] Bernstein CN, Benchimol EI, Bitton A, et al. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD. J Can Assoc Gastroenterol. 2019;2(Suppl 1):S73-S80.

[2] ShenHong, Tang Zhipeng, Tang Xudong, et al. Guidelines for TCM diagnosis and treatment of ulcerative colitis, a common digestive disease (basic level doctors' edition) . Chinese Journal of Traditional Chinese Medicine.2019,(9):4155-4160.

[3] Yu Li, Li Jingru. Summary of TCM syndrome differentiation treatment of ulcerative colitis patients . guide of china medicine.2018,(14):25-26.

[4] Mao Dewen, Tang Nong, Chen Yueqiao, et al. Analysis of the relationship between Yang dominating Yin subordinate and public views on Yin and Yang . Guangxi Traditional Chinese Medicine.2014,(5):41-42.

[5] Kaenkumchorn T , Wahbeh G . Ulcerative Colitis: Making the Diagnosis. Gastroenterology clinics of North America, 2020, 49(4):655-669.

[6] Li Rongrong, Yang Weixiao, Li Yi. Effect of Fuyang Huoxue Jiedu Recipe on Serum IL-17 and IL-10 Levels in Rats with Ulcerative Colitis . journal of traditional chinese medicine, Shandong.2020,(11):1228-1232.

[7] Venema W U , MD Voskuil, Dijkstra G , et al. The genetic background of inflammatory bowel disease: from correlation to causality. The Journal of Pathology, 2017, 241(2):146-158. 

[8] KMD Lange, Barrett J C . Understanding inflammatory bowel disease via immunogenetics. Journal of Autoimmunity, 2015, 64:91-100. 

[9] Yamamoto-Furusho J K , Y Gutiérrez-Grobe, JG López-Gómez, et al. The Mexican consensus on the diagnosis and treatment of ulcerative colitis. Revista De Gastroenterologia De Mexico, 2018,83(2):144-167.

[10] Chibbar R, Dieleman LA. Probiotics in the Management of Ulcerative Colitis. J Clin Gastroenterol. 2015;49 Suppl 1:S50-S55. 

[11] Stallmach A, Grunert P, Pieper D, Steube A. Colitis ulcerosa: Kann eine Modulation der intestinalen Mikrobiota eine langfristige Remission bedingen? [Ulcerative colitis: Does the modulation of gut microbiota induce long-lasting remission?]. Z Gastroenterol. 2019;57(7):834-842.

[12] Chaubey P, Momin M, Sawarkar S. Significance of Ligand-Anchored Polymers for Drug Targeting in the Treatment of Colonic Disorders. Front Pharmacol. 2020 Feb 25;10:1628. 

[13] Yamamoto-Furusho JK, Gutiérrez-Grobe Y, López-Gómez JG, Bosques-Padilla F, Rocha-Ramírez JL; Grupo del Consenso Mexicano de Colitis Ulcerosa Crónica Idiopática. The Mexican consensus on the diagnosis and treatment of ulcerative colitis. Rev Gastroenterol Mex. 2018 Apr-Jun;83(2):144-167.

[14] Selvaggi F, Pellino G, Ghezzi G,et al. A think tank of the Italian Society of Colorectal Surgery (SICCR) on the surgical treatment of inflammatory bowel disease using the Delphi method: ulcerative colitis. Tech Coloproctol. 2015 Oct;19(10):627-38.

[15] Anon. Epidemiology and pathogenesis of ulcerative colitis.. Gastroenterol Clin North Am, 2020, 49(4): 643-654.

[16] Qin Zhang, Jian Wan, Kai-chun Wu. Epidemiological investigation of canceration of ulcerative colitis: a national multicenter retrospective study .Chinese Journal of Inflammatory Bowel Disease, 2017(03):155-156-157-158-159.

[17] Shi Meijing, Li Ruiyan, Zhang Yubin. Research progress of signal pathway involved in treating ulcerative colitis with traditional Chinese medicine . Pharmaceutical progress.2016,(8):610-618.